Page last updated: 2024-10-20

pyrazinamide and Erysipelas

pyrazinamide has been researched along with Erysipelas in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Erysipelas: An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sattinger, E1
Meyer, S1
Costard-Jäckle, A1

Other Studies

1 other study available for pyrazinamide and Erysipelas

ArticleYear
Cutaneous tuberculosis mimicking erysipelas of the lower leg in a heart transplant recipient.
    Transplant international : official journal of the European Society for Organ Transplantation, 2011, Volume: 24, Issue:6

    Topics: Antitubercular Agents; Erysipelas; Ethambutol; Heart Transplantation; Humans; Isoniazid; Leg; Opport

2011